Publication | Closed Access

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

Afabev-cs Study ProtocolMedicinePathologyAfatinib AloneCancer TreatmentCancer GeneticsPhase 2OncologyRadiation OncologyLung CancerMolecular Oncology